Novartis AG ADR buy The Goldman Sachs Group, Inc.
Start price
30.05.24
/
50%
€92.80
Target price
30.05.25
€110.78
Performance (%)
9.91%
End price
31.05.25
€102.00
Summary
This prediction ended on 31.05.25 with a price of €102.00. With a performance of 9.91%, the BUY prediction by The_Goldman_Sachs_Gr for Novartis AG ADR closed with a slight gain. The_Goldman_Sachs_Gr has a follow-up prediction for Novartis AG ADR, but this time predicts that Novartis AG ADR is a Sell. Dividends of €3.87 are taken into consideration when calculating the performance. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novartis AG ADR | 2.954% | 2.954% | 25.514% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novartis AG ADR diskutieren
Novartis AG (NYSE: NVS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $120.00 price target on the stock.
Ratings data for NVS provided by MarketBeat
In the thread Trading Novartis AG ADR
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Novartis AG ADR
Novartis AG ADR
Start price
Target price
Perf. (%)
€106.50
12.09.25
12.09.25
€100.61
12.09.26
12.09.26
14.55%
09.01.26
09.01.26
